2023-11-14T17:06:54-06:00 2022-12-31 231406493 MORISON COGEN LLP 484 NORRISTOWN RD STE 100 BLUE BELL PA 19422 990 2022-01-01 232818395 NATIONAL COMPREHENSIVE CANCER NETWORK NATI 2156900300 3025 CHEMICAL ROAD 100 PLYMOUTH MEETING PA 19462 EILEEN BOSCIA CHIEF FINANCAL OFFICER 2156900300 2023-10-30 1 EILEEN BOSCIA 999009999 0 JOSEPH M KISTNER CPA P00157086 2674403000 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z ROBERT W CARLSON MD 3025 CHEMICAL ROAD 100 PLYMOUTH MEETING PA 19462 52064807 0 X WWW.NCCN.ORG X 1993 DE NCCN IS DEDICATED TO IMPROVING AND FACILITATING QUALITY, EFFECTIVE, EQUITABLE, AND ACCESSIBLE CANCER CARE SO ALL PATIENTS CAN LIVE BETTER LIVES. 34 34 173 1823 180458 100795 19295605 20368490 23520158 25922116 1382823 1791586 2012915 3982615 46211501 52064807 1828373 1875382 0 0 21445164 24176446 0 0 603459 6956874 9975697 30230411 36027525 15981090 16037282 114912916 133378564 24342347 38753139 90570569 94625425 X NCCN IS DEDICATED TO IMPROVING AND FACILITATING QUALITY, EFFECTIVE, EQUITABLE, AND ACCESSIBLE CANCER CARE SO ALL PATIENTS CAN LIVE BETTER LIVES. 0 0 17639835 22956977 NCCN GUIDELINES, NCCN CONTENT & EDUCATIONAL PROGRAMS:WITH EXPERTS FROM MAJOR ACADEMIC CANCER CENTERS, DEVELOP AND UPDATE CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF CANCER; INCLUDES BOTH DISTRIBUTION OF GUIDELINES FOR NON-COMMERCIAL USE AS WELL AS CERTAIN EDUCATIONAL CONFERENCES AND SYMPOSIA TO COMMUNICATE CONTENT FREE OF CHARGE. 4174181 2531388 PATIENT INFORMATION:DISSEMINATION OF PATIENT INFORMATION BASED ON GUIDELINES; DEVELOPMENT AND DISSEMINATION OF MEASURES TO ASSESS THE QUALITY OF CARE. 3578590 1875382 ONCOLOGY RESEARCH:DEVELOPMENT OF A CLINICAL RESEARCH NETWORK OF PHYSICIANS AT MEMBER ACADEMIC CANCER CENTERS TO FACILITATE THE CONDUCT OF STUDIES TO ADVANCE STATE-OF-THE-ART CANCER CARE. 3537822 614209 DEVELOPMENT OF OTHER PUBLIC AND PROFESSIONAL INFORMATION PROGRAMS TO FACILITATE ACCESS TO CANCER SPECIALTY SERVICES. 3537822 614209 28930428 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 245 0 1 173 1 1 1 0 0 0 0 0 0 0 1 0 X 34 34 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X EILEEN BOSCIA 2156900300 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 JOHN W SWEETENHAM MD FACP FRCP DIRECTOR, CHAIR 2.00 X 0 0 0 MATT KALAYCIO MD DIRECTOR, VICE-CHAIR 2.00 X 0 0 0 REBECCA L CAIRES MBA DIRECTOR 2.00 X 0 0 0 PATRICK J O'BRIEN MBA DIRECTOR, TREASURER 2.00 X 0 0 0 ROBERT H VONDERHEIDE MD DPHIL DIRECTOR 2.00 X 0 0 0 ROBIN FAMIGLIETTI PHD MBA FACHE DIRECTOR 2.00 X 0 0 0 RAVI SALGIA MD PHD DIRECTOR 2.00 X 0 0 0 CRAIG A BUNNELL MD MBA MPH DIRECTOR 2.00 X 0 0 0 KELVIN P LEE MD DIRECTOR 2.00 X 0 0 0 KENNETH H COWAN MD PHD DIRECTOR 2.00 X 0 0 0 NANCY E DAVIDSON MD DIRECTOR 2.00 X 0 0 0 TIMOTHY R DONAHUE MD DIRECTOR 2.00 X 0 0 0 DAVID G PFISTER MD DIRECTOR 2.00 X 0 0 0 LOUIS B HARRISON MD DIRECTOR 2.00 X 0 0 0 LISLE M NABELL MD DIRECTOR 2.00 X 0 0 0 AL B BENSON III MD FACP FASCO DIRECTOR 2.00 X 0 0 0 STEPHEN B EDGE MD FACS FASCO DIRECTOR 2.00 X 0 0 0 TIMOTHY J EBERLEIN MD DIRECTOR 2.00 X 0 0 0 ALBERTO S PAPPO MD DIRECTOR 2.00 X 0 0 0 WILLIAM E CARSON III MD DIRECTOR 2.00 X 0 0 0 DAVID S ETTINGER MD FACP FCCP DIRECTOR 2.00 X 0 0 0 JOSEPH A CALIFANO III MD DIRECTOR 2.00 X 0 0 0 ALAN P VENOOK MD DIRECTOR 2.00 X 0 0 0 SAMUEL M SILVER MD PHD MACP DIRECTOR 2.00 X 0 0 0 LAURA W GOFF MD MMHC MSCI DIRECTOR 2.00 X 0 0 0 ELIZABETH R PLIMACK MD MS DIRECTOR 2.00 X 0 0 0 SACHIN M APTE MD MBA MS DIRECTOR 2.00 X 0 0 0 RONDEEP BRAR MD DIRECTOR 2.00 X 0 0 0 RICHARD BOLD MD MBA DIRECTOR 2.00 X 0 0 0 RICHARD D SCHULICK MD MBA FACS DIRECTOR 2.00 X 0 0 0 LEE G WILKE MD FACS DIRECTOR 2.00 X 0 0 0 STEVEN J FRANK MD DIRECTOR 2.00 X 0 0 0 ROBERT R MCWILLIAMS MD MSC DIRECTOR 2.00 X 0 0 0 LORI C PICKENS MHA DIRECTOR 2.00 X 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 40.00 2.00 X 1894653 0 71500 GARY WEYHMULLER CHIEF OPERATING OFFICER 40.00 2.00 X 582858 0 63507 WUI-JIN KOH MD CHIEF MEDICAL OFFICER 40.00 X 573445 0 46208 CRYSTAL DENLINGER CHIEF SCIENTIFIC OFFICER 40.00 X 354476 0 36362 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 40.00 2.00 X 306400 0 44441 KRISTINA M GREGORY VP, CLINICAL INFORMATION P 40.00 X 318558 0 43894 LINDA LEACH VP, ADMIN. & HUMAN RESOURC 40.00 X 283463 0 40861 BETH GAFFNEY VP - US & GLOBAL BUSINESS 40.00 X 259241 0 72451 JENNIFER TREDWELL VP, MARKETING & COMMUNICAT 40.00 X 219984 0 61259 JOSEPH JUNOD SENIOR DIRECTOR, IT 40.00 X 184534 0 52539 4977612 0 533022 63 0 1 0 CLINICAL CARE OPTIONS LLC 12001 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 MEDICAL EDUCATION PROGRAM SERVICES 1657443 ITC TRANSLATIONS USA INC 900 EAST INDIANTOWN ROAD SUITE 302 JUPITER FL 33477 PROFESSIONAL SERVICES 574358 HEALTH RESEARCH INC ELM AND CARLTON STREETS BUFFALO NY 14263 RESEARCH 365696 ALCOM PRINTING GROUP INC 140 CHRISTOPHER LANE HARLEYSVILLE PA 19438 FULFILLMENT - SHIPPING & POSTAGE 327915 MORGAN LEWIS & BOCKIUS LLP PO BOX 8500 S-6050 PHILADELPHIA PA 19178 LEGAL 326687 20 4612500 15755990 20368490 LICENSE FEES 900099 9440081 9440081 PERMISSION FEES 900099 7891274 7891274 GUIDELINE DISTRIBUTION 900099 2790840 2790840 SUBSCRIPTIONS 900099 2088088 2088088 CONSULTING FEES 900099 1984323 1984323 1727510 1727510 25922116 1791586 1791586 3802157 3802157 ADVERTISING 541800 180458 180458 180458 52064807 25922116 180458 5593743 1875382 1875382 3711830 2830502 843304 38024 15144284 13788377 929019 426888 907093 800017 84585 22491 3253308 2869276 303364 80668 1159931 1023009 108162 28760 365654 250208 115446 75450 16500 58950 1524896 1182283 342613 153354 93953 59401 258615 73839 184776 747333 293214 454119 1950880 1950880 853791 721976 128210 3605 1861178 1861178 437855 437855 197992 101 197891 HONORARIA 300320 300320 PRINTING AND PUBLICATIO 271053 250527 20526 CATERING 256125 211975 44150 FEES 189934 178444 11490 531267 309347 218897 3023 36027525 28930428 6493638 603459 28525911 25536329 12338596 12530131 5698774 4661852 1570910 1480797 338510 295880 1242211 797065 3822861 2379173 1783434 1443688 63414570 72927716 0 13705106 114912916 133378564 3614196 3107967 20728151 21024013 0 14621159 24342347 38753139 X 86892520 89267100 3678049 5358325 90570569 94625425 114912916 133378564 16037282 -11982426 0 X X 0 1 X 1 0 X 16587411 17231822 20946288 19295605 20368490 94429616 16587411 17231822 20946288 19295605 20368490 94429616 2428196 92001420 1482180 2187970 2455722 3140006 5593743 14859621 139061 173053 145876 174063 101795 733848 17540902 19536519 21973829 23520158 25922116 108493524 218516609 0.42100 0.43150 X SCHEDULE A - PART II SECTION B LINE 10 OTHER INCOME INCLUDES THE FOLLOWING ITEMS: LICENSE FEE REVENUE FOR LICENSING OF NCCN PRODUCTS $9,440,081 PERMISSION FEES 7,891,274 CONSULTING REVENUE 1,984,323 GUIDELINE DISTRIBUTION 2,790,840 SUBSCRIPTION REVENUE FROM THE NCCN COMPENDIA, CHEMOTHERAPY ORDER TEMPLATES AND FLASH UDPATES 2,088,088 TUITION FEES FOR NCCN ACADEMY 565,507 TRENDS SURVEY FEES FOR NCCN TRENDS REPORTS 366,608 EXHIBIT FEES FOR EXHIBITING AT NCCN EDUCATIONAL PROGRAMS 411,823 REGISTRATION FEES FOR NCCN EDUCATIONAL PROGRAMS 334,870 FELLOWSHIP GRANTS 48,702 TOTAL $25,922,116 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 16163 16163 36011362 36027525 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 11281 8037 12999 16163 48480 250000 250000 250000 250000 1000000 1500000 SCHEDULE C PART II-A, LINE 1 LOBBYING EXPENDITURES ON PART II-A, LINE 1 OF $16,163 INCLUDE STAFF TIME ASSOCIATED WITH LOBBYING ACTIVITIES INCLUDING THE REDUCING HEREDITARY CANCER ACT OF 2021, THE CANCER PATIENT EQUITY ACT HR 5377, THE DIVERSE TRIALS ACT, THE IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT, THE INCREASING ACCESS TO LUNG CANCER SCREENING ACT, ISSUES OF SURVIVORSHIP CARE AND RISK REDUCING INTERVENTIONS, AS WELL AS, MEETINGS WITH VARIOUS MEMBERS OF CONGRESS AND FEDERAL AGENCIES. 1160795 402825 757970 2662066 1976348 685718 1443688 RIGHT OF USE ASSETS - OPERATING LEASES 13705106 13705106 LEASE LIAB. - OPERATING LEASES 1619584 LEASE LIAB. - OPER. LEASE - (LT) 13001575 14621159 40082381 -11982426 -11982426 52064807 0 52064807 36027525 0 36027525 0 36027525 EUROPE 0 0 PROGRAM SERVICES EDUCATIONAL PROGRAM 134262 SOUTH AMERICA 0 0 PROGRAM SERVICES CLINICAL PRACTICE GUIDELINES 40000 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES CLINICAL PRACTICE GUIDELINES 23721 0 0 0 0 0 0 197983 0 197983 0 0 0 0 0 0 PART III ACCOUNTING METHOD: SCHEDULE F - PART I LINE 3(F) THE METHOD USED TO ACCOUNT FOR THE ORGANIZATION'S EXPENDITURES IS THE ACCRUAL BASIS OF ACCOUNTING. THIS IS THE SAME METHOD USED IN THE ORGANIZATION'S FINANCIAL STATEMENTS. 1 ADVENTHEALTH ORLANDO 601 E ROLLINS ST SUITE 400 ORLANDO FL 32803 590724459 501(C)(3) 14392 0 RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BP320 BOSTON MA 02215 043320640 501(C)(3) 104685 0 RESEARCH CITY OF HOPE COMP CANCER CTR 1500 E DUARTE RD DUARTE CA 91010 951683875 501(C)(3) 75000 0 RESEARCH FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232003072 501(C)(3) 158980 0 RESEARCH H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 71960 0 RESEARCH HEALTH RESEARCH INC ROSEWELL PARK CANCER CENTER - ELM AND CARLTON STREETS BUFFALO NY 14263 141402155 501(C)(3) 365696 0 RESEARCH HUNTSMAN CANCER INSTITUTE 2000 CIRCLE OF HOPE SALT LAKE CITY UT 84112 876000525 501(C)(3) 13991 0 RESEARCH JOHNS HOPKINS UNIVERSITY 733 N BROADWAY SUITE 117 BALTIMORE MD 21205 520595110 501(C)(3) 16151 0 RESEARCH KUMC RESEARCH INSTITUTE INC 3901 RAINBOW BLVD MAIL STOP 1039 KANSAS CITY KS 66160 481108830 501(C)(3) 53656 0 RESEARCH REGENTS OF UNIVERSITY OF CO DENVER 1800 GRANT ST 800 DENVER CO 80203 846000555 501(C)(3) 59990 0 RESEARCH MASS GENERAL HOSPITAL 101 HUNTINGTON AVENUE SUITE 210 BOSTON MA 02199 042697983 501(C)(3) 155070 0 RESEARCH MAYO CLINIC 200 FIRST STREET SW ROCHESTER MN 55905 416011702 501(C)(3) 97582 0 RESEARCH NEW ENGLAND CANCER SPECIALISTS 100 CAMPUS DRIVE SCARBOROUGH ME 04074 221487173 501(C)(3) 12436 0 RESEARCH NORTHWESTERN UNIVERSITY HEALTH SYSTEM 750 N LAKE SHORE DRIVE 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 43176 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA 1855 FOLSOM STREET ROOM 425 SAN FRANCISCO CA 94143 946036493 501(C)(3) 37000 0 RESEARCH STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(C)(3) 134140 0 RESEARCH ROSWELL PARK COMPREHENSIVE CANCER CENTER ELM CARLTON STREETS BUFFALO NY 14263 161552370 501(C)(3) 60000 0 RESEARCH THE TRUSTEES OF THE U OF PENN 801 SPRUCE ST PHILADELPHIA PA 19107 231352685 501(C)(3) 127604 0 RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE AVE UNIT 176 HOUSTON TX 77030 746001118 501(C)(3) 102000 0 RESEARCH PENN MEDICINE CHESTER COUNTY HOSPITAL 440 E MARSHALL STREET SUITE 101 WEST CHESTER PA 19380 230469150 501(C)(3) 27250 0 RESEARCH UNIVERSITY OF WASHINGTON 825 EASTLAKE AVENUE SEATLE WA 98109 916001537 115 50772 0 RESEARCH VANDERBILT UNIVERSITY MEDICAL CENTER DEPARTMENT OF FINANCE AT40303 ATLANTA GA 311920303 620476822 501(C)(3) 6542 0 RESEARCH UT SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD DALLAS TX 75390 756002868 501(C)(3) 13936 0 RESEARCH UNIVERSITY HOSP CLEVELAND MC 11100E EUCLID AVENUE CLEVELAND OH 44106 341018992 501(C)(3) 68423 0 RESEARCH 23 1 PART I, LINE 2: NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) ENTERS INTO RESEARCH GRANT AGREEMENTS WITH INSTITUTIONS TO CONDUCT RESEARCH FOR INDIVIDUAL STUDY PROJECTS APPROVED BY NCCN'S SCIENTIFIC REVIEW COMMITTEES. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY GRANT RECIPIENTS ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE PRINCIPAL INVESTIGATORS AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE NCCN SCIENTIFIC REVIEW COMMITTEES. PRINCIPAL INVESTIGATORS OR THEIR INSTITUTIONS MUST ATTEST THAT THEY WILL ABIDE BY THE TERMS OF NCCN RESEARCH AGREEMENTS AND THAT THE PRINCIPAL INVESTIGATORS HAVE NOT BEEN DEBARRED OR DISQUALIFIED UNDER ANY RELEVANT STATUTES. IF AN INSTITUTION DOES NOT COMMENCE A STUDY WITHIN THE REQUIRED TIMELINE, NCCN MAY REQUEST THE INVESTIGATOR SUBMIT A CORRECTIVE ACTION PLAN FOR NCCN'S APPROVAL OR TERMINATE THE STUDY. DURING THE TERM OF THE GRANT, INSTITUTIONS REPORT TO NCCN ON A MONTHLY OR QUARTERLY BASIS. REPORTS INCLUDE AN UPDATE ON THE STATUS AND PROGRESS OF THE FUNDED STUDIES INCLUDING AN ASSESSMENT OF TOTAL ENROLLMENT OR STUDY PROGRESS, ELIGIBILITY, AND ACCRUAL OF PATIENTS AS APPLICABLE. IN CONSIDERATION FOR PERFORMANCE OF THE STUDY, NCCN DISTRIBUTES GRANT MONIES TO INSTITUTIONS WHEN CERTAIN BENCHMARK MILESTONES ARE MET AND FINAL PAYMENT IS DISBURSED UPON RECEIPT OF THE FINAL BENCHMARK MILESTONE IN THE FORM OF FINAL REPORTS AND / OR MANUSCRIPTS. INSTITUTIONS THAT DO NOT ENROLL OR COMPLETE THEIR STUDIES FULLY ARE REQUIRED TO RECONCILE STUDY EXPENSES AT TERMINATION OR COMPLETION AND RETURN UNUSED FUNDS TO NCCN WHICH ARE IN TURN RETURNED TO THE GRANTOR. X X X X X X 0 0 0 0 0 0 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 857351 0 1037302 0 0 0 30500 0 41000 0 1966153 0 0 0 GARY WEYHMULLER CHIEF OPERATING OFFICER 522858 0 60000 0 0 0 30500 0 33007 0 646365 0 0 0 WUI-JIN KOH MD CHIEF MEDICAL OFFICER 513285 0 60160 0 0 0 30500 0 15708 0 619653 0 0 0 CRYSTAL DENLINGER CHIEF SCIENTIFIC OFFICER 325676 0 28800 0 0 0 20654 0 15708 0 390838 0 0 0 KRISTINA M GREGORY VP, CLINICAL INFORMATION P 284974 0 33584 0 0 0 28800 0 15094 0 362452 0 0 0 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 276549 0 29851 0 0 0 27844 0 16597 0 350841 0 0 0 BETH GAFFNEY VP - US & GLOBAL BUSINESS 231093 0 28148 0 0 0 25783 0 46668 0 331692 0 0 0 LINDA LEACH VP, ADMIN. & HUMAN RESOURC 253416 0 30047 0 0 0 25767 0 15094 0 324324 0 0 0 JENNIFER TREDWELL VP, MARKETING & COMMUNICAT 195973 0 24011 0 0 0 20591 0 40668 0 281243 0 0 0 JOSEPH JUNOD SENIOR DIRECTOR, IT 173875 0 10659 0 0 0 11911 0 40628 0 237073 0 0 0 FORM 990, PART I, LINE 6, VOLUNTEERS: NCCN HAD 1,823 VOLUNTEERS COMMIT APPROXIMATELY 44,677 VOLUNTEER HOURS AS PANEL MEMBERS UPDATING EACH OF THE NCCN GUIDELINES FOR CANCER TREATMENT. FORM 990, PART VI, SECTION B, LINE 11B NCCN PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW AND APPROVAL PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN REQUIRES OFFICERS, DIRECTORS, AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. SENIOR NCCN STAFF REVIEW THE CONFLICT OF INTEREST FORMS ANNUALLY, PROVIDE A REPORT TO THE EXECUTIVE COMMITTEE AND TAKE CORRECTIVE ACTION IF NEEDED. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF NCCN'S CHIEF EXECUTIVE OFFICER (CEO) IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIRMAN OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. A SALARY COMPARABILITY STUDY AND SURVEY WAS COMPLETED DURING 2022. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO NCCN'S EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. EACH YEAR, THE EXECUTIVE COMMITTEE OF NCCN'S BOARD OF DIRECTORS RECEIVES INFORMATION REGARDING THE CEO'S PAST SALARY HISTORY AS WELL AS THE CEO'S ACCOMPLISHMENTS. NCCN'S EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL TO REVIEW THIS INFORMATION AND TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. FORM 990, PART VI, SECTION B, LINE 15B THE COMPENSATION OF NCCN'S CHIEF OPERATING OFFICER (COO), CHIEF MEDICAL OFFICER, CHIEF SCIENTIFIC OFFICER, AND CHIEF FINANCIAL OFFICER (CFO) IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CEO OF NCCN. A SALARY COMPARABILITY STUDY AND SURVEY WAS COMPLETED DURING 2022. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. THE CEO REVIEWS THE SALARY STUDY AND SURVEY TO DETERMINE THE COMPENSATION FOR THE ABOVE KEY EMPLOYEES OF NCCN. FORM 990, PART VI, SECTION C, LINE 19 NCCN MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NCCN FOUNDATION 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 271536314 FOUNDATION DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 NCCN FOUNDATION L 1844240 FMV NCCN FOUNDATION O 1076846 FMV NCCN FOUNDATION P 99515 FMW PART V LINE 2, COLUMN C PROFESSIONAL FEES $30,592 TRAVEL AND MEETINGS 25,832 OFFICE EXPENSE 8,323 SUPPLIES AND PRINTING 5,596 OTHER EXPENSES 7,118 RESEARCH PROGRAM 2,604 MARKETING AND PUBLIC RELATIONS 19,409 TELEPHONE 41 TOTAL PART V - LINE 2(3) $99,515